Markets In a report released yesterday, Marie Thibault from BTIG maintained a Hold rating on Masimo (MASI – Research Report). The company’s shares closed last Monday at $242.67. According to TipRanks.com, Thibault is a 5-star analyst with an average return of 74.1% and a 61.5% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Edwards Lifesciences, and Irhythm Technologies. Masimo has an analyst consensus of Moderate Buy, with a price target consensus of $297.50, implying a 20.3% upside from current levels. In a report issued on April 12, Needham also assigned a Hold rating to the stock. Based on Masimo’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $295 million and net profit of $70.67 million. In comparison, last year the company earned revenue of $248 million and had a net profit of $52.92 million.